{"disease":{"id":"liver-cancer-primary-and-metastatic","name":"liver cancer primary and metastatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07410676","title":"EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":83,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT07303725","title":"Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Palo Alto Veterans Institute for Research","has_results":false},{"nct_id":"NCT07459309","title":"Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06229080","title":"Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Next Biomedical Co., Ltd.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}